Phibro Animal Health

Phibro Animal Health Corporation is a leading global company focused on animal health and mineral nutrition, primarily serving the food production sector. The company develops, manufactures, and markets a wide range of products for various food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its diverse product portfolio encompasses animal health solutions such as antibacterials, anticoccidials, nutritional specialty products, and vaccines, along with mineral nutrition offerings. Phibro operates through three main segments: Animal Health, Mineral Nutrition, and Performance Products, with the majority of its revenue generated from the Animal Health segment. By concentrating exclusively on enhancing animal health and nutrition, Phibro aims to address the increasing global demand for animal protein.

Glenn David

CFO

Richard Johnson

interim CFO

7 past transactions

KoVax

Acquisition in 2018
KoVax Ltd. was established in 2003 in order to develop, manufacture and market a vaccine to eradicate fish diseases. Kovax is the only company in the world that produced and markets an efficient and safe vaccine against CyHV3 (KHV) disease.

Biotay

Acquisition in 2017
BIOTAY SA manufactures animal health and nutritional products.

OAE Holdings Pty Ltd

Acquisition in 2014
OAE Holdings Pty Ltd develops, produces, and markets animal health products primarily to the poultry sector.

Aqua-Vet

Acquisition in 2014
Aqua-Vet Ltd. operates as a technical consulting and contract research organization focused on the global aquaculture market.

ABIC Biological Laboratories

Acquisition in 2009
ABIC Biological Laboratories Ltd. develops, produces, and markets animal health products primarily to the poultry sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.